A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma (Q61627994)
Jump to navigation
Jump to search
scientific article published on 01 September 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma |
scientific article published on 01 September 2012 |
Statements
A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma (English)
Jenette Creaney
Arman Hasani
Agatha van der Schaaf
Amanda Segal
Michael J Millward
Ian M Dick
Michael J Byrne
1 September 2012